Thomas Lila
About Thomas Lila
Thomas Lila is the Associate Director of Translational Development and Diagnostics at Bristol-Myers Squibb in the San Francisco Bay Area, with a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley.
Title
Thomas Lila holds the title of Associate Director of Translational Development and Diagnostics at Bristol-Myers Squibb. He has held this title since December 2019 and works in the San Francisco Bay Area.
Current Role: Bristol-Myers Squibb
Thomas Lila currently serves as the Associate Director of Translational Development and Diagnostics at Bristol-Myers Squibb. Since December 2019, he has been contributing to the company's initiatives from the San Francisco Bay Area, bringing extensive knowledge in pharmaceutical mechanisms and clinical translation.
Previous Experience at Celgene Corporation
Before joining Bristol-Myers Squibb, Thomas Lila was the Associate Director of Translational Oncology at Celgene Corporation. He held this position from 2017 to 2019, operating out of the San Francisco Bay Area. His role focused on translational activities in oncology.
Roles at Photoswitch Bioscience and Arete Therapeutics
Thomas Lila worked as Lead Biologist at Photoswitch Bioscience from 2010 to 2017. Earlier, he served as Associate Director of Discovery Biology at Arete Therapeutics for 11 months in 2009. Both roles were based in the San Francisco Bay Area.
Career Foundations at Cytokinetics and Microcide/Essential Therapeutics
Thomas Lila started his career in the biopharmaceutical industry as a Research Biologist at Microcide/Essential Therapeutics from 1997 to 2002. He later advanced to being a Senior Scientist in Lead Discovery at Cytokinetics Inc., where he worked from 2002 to 2008.
Education in Molecular and Cell Biology
Thomas Lila holds a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley. His academic background has supported his focus on bioassay technology development and translational science throughout his career.
Expertise and Interests
Thomas Lila has a robust interest in pharmaceutical mechanisms, clinical translation, and bioassay technology development. His extensive professional experience in translational development and diagnostics further emphasizes his specialization in these domains.